Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Limited (NURPF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NURPF · as of Jun 9, 2026
Key Statistics
Explore Neuren Pharmaceuticals Limited Data
nurpf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
nurpf competitorsNURPF
ANEB
ASMB
AVTE
CERE
CMPXStock Performance
Full HistoryAbout Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Limited is a biopharmaceutical company specializing in the development of treatments for neurological conditions. Their leading therapeutic compound, trofinetide, is currently u…
what is neuren pharmaceuticals limited · nurpf stock overview · neuren pharmaceuticals limited company profile · who is neuren pharmaceuticals limited ceo · nurpf OTC · neuren pharmaceuticals limited headquarters · neuren pharmaceuticals limited business segments
About Stock Overview & Key Data
Neuren Pharmaceuticals Limited (NURPF) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 4, 2009. As of the latest trading session, NURPF stock price is $9.25, with a market capitalization of $1.2B. The stock has returned +4.40% over the past 12 months and -28.35% year-to-date.
In fiscal year 2025, Neuren Pharmaceuticals Limited reported revenue of $64.6M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Neuren Pharmaceuticals Limited (NURPF) stock price is $9.25. The stock is traded on OTC under the ticker symbol NURPF. The 52-week range is $7.70 – $14.80.